Home Log In
Tuesday, October 6, 2026
28.3
C
Bengaluru
Hot topics
Breaking Performance Barriers
Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai
Don’t Do Digital for the Sake of Doing Digital
Catalyzed by the pandemic, the pharma industry quickly progressed from being digitally agnostic to a state of preparedness.
The shift required the industry to experiment with technology in its customer-facing plans, which resulted in many cases the creation of random acts of digital, often without a cohesive overarching strategy.
Can pharma do better? The answer lies in understanding the utility of their digital assets while building a mindset to transform, and ensuring that teams within the organization do not work at cross-purposes.
Creating A Winning Sales Organisation – Workshop Announcement
MedicinMan catches up with Deep Bhandari - Advisor at UCB where he...
Mounjaro Upends Semaglutide Gold Rush: IPM May 2026
1. The Eli Lilly & Mounjaro Disruption: A New...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Hot topics
Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy
In 1989, oncology in India was not a business...
Deep Bhandari: Human capital holds the highest value for organizations
DigiStorm 2018 was held on 11 September at the Lalit Ashok in Bangalore. The event was headlined by Prabir Jha – President & Global Chief People Officer, Cipla. Deep Bhandari – Editorial Board Member, MedicinMan, gives us the highlights of the post-lunch session.
From Overuse to Overreaction: Recalibrating India’s C-Section Debate
India’s caesarean section debate is drifting toward polarisation.
On one...
Elephant in the Doctor’s Clinic: Indian Pharma Medical Rep
For decades, the Medical Representative has been the backbone...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
10 Years of Pharma M&A — Who’s Really Benefited?
Pharmaceutical M&A is usually discussed in the language of...
MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More
Headlines
Indian Pharma Is Two Industries Wearing One Label
Indian pharma is often discussed as one sector. In...
Why Is the World’s Pharmacy Failing to Protect Patients from Harm?
This MedicinMan Intelligence Report follows a disturbing trail—from Arun...
Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.
With over three decades of experience in the pharmaceutical...
The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?
India’s anaemia challenge is not simply about access to...
Newsletter
Get important news delivered directly to your inbox and stay connected!